The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):

Seasoned scientist with 20+ years of experience leading complex in vitro and in vivo studies in BSL-3/BSL-4 laboratories to drive delivery of vaccines, clinical diagnostics, and countermeasure developments to emerging pathogens and natural and man-made biological threats. Subject-matter expert in biosafety, biorisk, immunology, pathogenesis, host-pathogen interactions, virology, and vaccinology, underpinned by a PhD in immunology and microbiology. Proven thought leader in MCM development, biosurveillance, and biocontainment, evidenced by multiple patents, 100+ peer-reviewed published manuscripts, abstracts, and reviews, and 20+ speaking engagements at international universities, executive branches of the federal government, private contractors, and global seminars and advisory panels. Subject matter expert for DoD, FDA, and other U.S. government agencies, and international global health NGOs and organizations. For the past five years, Dr. Olinger has been focused on One Health program development with partners in the U.S., Africa, India, South and Central America.